Large Cap High Growth Potential

Results

768

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

768 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$535.69	0.9%	61.9%	US$12.8b	US$678.86	10.9	59.7%	n/a	Pharmaceuticals & Biotech
	GH	US$148.07	-6.5%	224.4%	US$20.7b	US$171.08	18.2	55.8%	n/a	Healthcare
	002709	CN¥36.09	-5.4%	86.8%	CN¥67.8b	CN¥65.08	25.5	28.9%	0.7%	Materials
	MOD	US$227.88	-2.7%	143.2%	US$12.2b	US$340.86	99.6	49.2%	n/a	Capital Goods
	688072	CN¥764.46	-10.1%	364.2%	CN¥184.4b	CN¥526.93	134.6	35.2%	0.04%	Semiconductors
	6223	NT$5,920.00	-6.6%	466.5%	NT$534.5b	NT$7,684.55	157.6	57.5%	0.4%	Semiconductors
	001389	CN¥174.31	-6.3%	160.5%	CN¥72.3b	CN¥248.67	70.5	32.7%	0.4%	Tech
	2368	NT$975.00	-3.9%	198.6%	NT$468.5b	NT$1,485.00	43.5	38.2%	1.0%	Tech
	RHM	€990.30	1.1%	-45.4%	€46.1b	€1,697.85	43.9	30.6%	1.2%	Capital Goods
	NVDA	US$203.28	-0.1%	18.6%	US$4.9t	US$302.31	30.8	22.8%	0.5%	Semiconductors
	LITE	US$765.55	-0.3%	637.2%	US$57.0b	US$1,104.89	135.7	56.3%	n/a	Tech
	CRDO	US$212.07	-10.5%	121.5%	US$37.8b	US$278.50	83.7	27.7%	n/a	Semiconductors
	SPCX	US$119.85	-13.9%	n/a	US$1.6t	US$240.04	81.8	60.7%	n/a	Telecom
	AXSM	US$221.64	-2.9%	102.1%	US$11.8b	US$280.39	16.1	57.0%	n/a	Pharmaceuticals & Biotech
	6990	HK$511.50	2.7%	35.3%	HK$120.5b	HK$563.10	51.3	45.5%	n/a	Pharmaceuticals & Biotech
	6082	HK$38.70	-8.4%	n/a	HK$84.0b	HK$88.52	78.7	116.9%	n/a	Semiconductors
	688183	CN¥110.23	-13.1%	125.0%	CN¥84.6b	CN¥159.00	53.2	35.5%	0.8%	Tech
	600183	CN¥135.67	-8.3%	252.8%	CN¥299.6b	CN¥137.08	83.9	28.6%	1.2%	Tech
	002384	CN¥231.00	-11.3%	325.3%	CN¥396.9b	CN¥188.00	206.4	73.1%	0%	Tech
	7769	NT$6,465.00	1.1%	309.2%	NT$1.1t	NT$9,241.87	80.7	43.1%	1.0%	Semiconductors
	ASELS	₺354.50	0.6%	100.5%	₺1.6t	₺388.49	49.7	51.1%	0.1%	Capital Goods
	SMTC	US$125.88	-4.7%	137.2%	US$11.6b	US$205.25	10.8	74.6%	n/a	Semiconductors
	300394	CN¥231.00	-15.5%	260.9%	CN¥232.9b	CN¥322.37	116.0	39.8%	0.2%	Tech
	BE	US$197.06	-15.6%	677.1%	US$61.1b	US$283.16	9291.0	45.5%	n/a	Capital Goods

Page 1 of 22